Navigation Links
Finn, Warnke & Gayton Announces A New Service For Biotechnology Firms - A Platform To Sell Intellectual Property
Date:12/8/2009

WELLESLEY HILLS, Mass., Dec. 8 /PRNewswire/ -- Joseph F. Finn, Jr., C.P.A. Managing Partner of Finn, Warnke & Gayton announced today that the firm is offering a sales platform for biotechnology companies to sell their intellectual property. According to industry sources, many of these enterprises have intellectual property sitting dormant in various stages of development due to funding, scientific or regulatory issues.

Finn noted that the firm's experience in selling the intellectual property of ActivBiotics, Spherics, Prospect Therapeutics, Alpha Beta Technologies and Epix Pharmaceuticals has given it the opportunity to develop a database of active buyers and create a legal platform to conduct sales. It has also created a steady flow of inquires from biotech firms and individuals regarding the firm's future offerings of intellectual property.

Persons interested in discussing this service should contact Joseph F. Finn, Jr., Christopher J. Finn, or Paul Bolger at 781-237-8840 or Link';s.eVar3=s.prop5;s.prop15='78779862';s.tl(this,'o','ExternalLink');">jffinnjr@earthlink.net.

About Finn, Warnke & Gayton

For over 35 years, Finn, Warnke & Gayton has been one of the region's most respected business consulting and accounting firms. In addition to our new service, our team of professionals provides management consulting services to distressed enterprises, accounting, trustee, and agency services related to bankruptcy and insolvency matters, advisory services to financial institutions, interim management, and traditional tax and accounting services to corporations and individuals. For more information on the firm, please visit our website at Link';s.eVar3=s.prop5;s.prop15='78779862';s.tl(this,'o','ExternalLink');">finnwarnkegayton.com.

SOURCE Finn, Warnke & Gayton


'/>"/>
SOURCE Finn, Warnke & Gayton
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Spherics, Inc. Assigns Assets to Joseph F. Finn, Jr., C.P.A.
2. Prospect Therapeutics, Inc. Assigns All Its Assets to Joseph F. Finn, Jr., C.P.A. for the Benefit of Its Creditors
3. Stevens to host Nanoscience/Nanotechnology & Corrosion symposium, Nov. 13
4. SACHEM Launches New Products for High Purity Advanced Ceramic Powders : Avanta AC™ Advanced Ceramics Solutions Offer Unique Advantages over Inorganic Bases in the Manufacture of Advanced Ceramic Nanoparticles
5. SACHEM Launches New Products for High Purity Advanced Ceramic Powders : Avanta AC™ Advanced Ceramics Solutions Offer Unique Advantages over Inorganic Bases in the Manufacture of Advanced Ceramic Nanoparticles
6. Polymathic Analytical Labs Debuts at World's Largest Medical Design & Manufacturing Exhibition
7. M. D. Anderson Automates Laboratory Workflow with Stone Bond Technologies : EE-LIMS™ from Stone Bond Technologies Will Document Activities within the Laboratory Workflow at the siRNA Facility, Increasing Throughput, While Reducing Risks
8. Ovalum Ltd. Announces Sales Launch of CiTop™ Product-Line in Europe
9. Ovalum Ltd. Received Clearance to Market the CiTop™ Product-Line in Israel
10. Ovalum Ltd. Announces Success in Coronary Cases Using CiTop™ ExPander™ Guidewire
11. Argonne researchers win 2 R&D 100 Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... platform specifically designed for life science researchers to analyze and interpret datasets, ... Franklin, who made a major contribution to the discovery of the double-helix ...
(Date:10/11/2017)... Palo Alto, CA, USA (PRWEB) , ... October 11, 2017 , ... ... is set to take place on 7th and 8th June 2018 in San Francisco, ... and policy influencers as well as several distinguished CEOs, board directors and government officials ...
(Date:10/11/2017)... ... 2017 , ... Disappearing forests and increased emissions are the main causes of ... year. Especially those living in larger cities are affected by air pollution related diseases. ... most pollution-affected countries globally - decided to take action. , “I knew I had ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give ... Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles ...
Breaking Biology Technology:
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/29/2017)... 2017  higi, the health IT company that operates ... America , today announced a Series B investment ... EveryMove. The new investment and acquisition accelerates higi,s strategy ... transform population health activities through the collection and workflow ... higi collects and secures data today on behalf of ...
(Date:3/24/2017)... 2017 Research and Markets has announced the ... & Trends - Industry Forecast to 2025" report to their ... The Global ... CAGR of around 15.1% over the next decade to reach approximately ... the market estimates and forecasts for all the given segments on ...
Breaking Biology News(10 mins):